Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-06

Clinical Trial Update: Selenium for Musculoskeletal Health [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on selenium for musculoskeletal health in osteoporosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selenium (selenium)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED